Alivus Life Sciences Ltd

📄 Alivus Life Sciences Receives Tax Assessment Order for FY 2022–23

- Assessment order received from Income Tax Department on March 20, 2026, at approximately 7:30 PM.

- Pertains to financial year 2022–23 (Assessment Year 2023–24).

- Tax demand raised: ₹2,60,67,810, including applicable interest.

- Demand due to disallowances of expenditure under Section 37(1) of the Income Tax Act.

- Company states no material financial or operational impact.

- Order is appealable; company is assessing the right to appeal.